Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Darusentan> ?p ?o }
Showing triples 1 to 76 of
76
with 100 triples per page.
- Darusentan abstract "Darusentan (LU-135252; HMR-4005) is an endothelin receptor antagonist. Gilead Colorado, a subsidiary of Gilead Sciences, under license from Abbott Laboratories, is developing darusentan for the potential treatment of uncontrolled hypertension.In June 2003, Myogen licensed the compound from Abbott for its application in the cancer field.In May 2007, a randomized, double-blind, active control, parallel assignment, safety and efficacy phase III trial was initiated in subjects who had completed the maintenance period of the DAR-312 study.".
- Darusentan atcPrefix "none".
- Darusentan casNumber "171714-84-4".
- Darusentan fdaUniiCode "33JD57L6RW".
- Darusentan iupacName "(2S)-2-(4,6-Dimethoxypyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic acid".
- Darusentan pubchem "177236".
- Darusentan thumbnail Darusentan.png?width=300.
- Darusentan wikiPageID "21714783".
- Darusentan wikiPageLength "2475".
- Darusentan wikiPageOutDegree "10".
- Darusentan wikiPageRevisionID "679804737".
- Darusentan wikiPageWikiLink Abbott_Laboratories.
- Darusentan wikiPageWikiLink Category:Endothelin_receptor_antagonists.
- Darusentan wikiPageWikiLink Category:Phenol_ethers.
- Darusentan wikiPageWikiLink Category:Pyrimidines.
- Darusentan wikiPageWikiLink Endothelin_receptor_antagonist.
- Darusentan wikiPageWikiLink Gilead_Sciences.
- Darusentan wikiPageWikiLink Hypertension.
- Darusentan wikiPageWikiLink Liver.
- Darusentan wikiPageWikiLink Myogen.
- Darusentan wikiPageWikiLink Phase_III.
- Darusentan wikiPageWikiLink Phases_of_clinical_research.
- Darusentan wikiPageWikiLinkText "Darusentan".
- Darusentan atcPrefix "none".
- Darusentan c "22".
- Darusentan casNumber "171714".
- Darusentan chembl "23261".
- Darusentan chemspiderid "154336".
- Darusentan eliminationHalfLife "45000.0".
- Darusentan h "22".
- Darusentan hasPhotoCollection Darusentan.
- Darusentan inchi "1".
- Darusentan inchikey "FEJVSJIALLTFRP-LJQANCHMBS".
- Darusentan iupacName "-2".
- Darusentan iupharLigand "3508".
- Darusentan metabolism Liver.
- Darusentan molecularWeight "410.42".
- Darusentan n "2".
- Darusentan o "6".
- Darusentan pubchem "177236".
- Darusentan routesOfAdministration "Oral".
- Darusentan smiles "COC1=CCOC".
- Darusentan stdinchi "1".
- Darusentan stdinchikey "FEJVSJIALLTFRP-LJQANCHMSA-N".
- Darusentan unii "33".
- Darusentan verifiedfields "changed".
- Darusentan verifiedrevid "384091933".
- Darusentan watchedfields "changed".
- Darusentan wikiPageUsesTemplate Template:Drugbox.
- Darusentan wikiPageUsesTemplate Template:Peptidergics.
- Darusentan wikiPageUsesTemplate Template:Pharma-stub.
- Darusentan wikiPageUsesTemplate Template:Reflist.
- Darusentan subject Category:Endothelin_receptor_antagonists.
- Darusentan subject Category:Phenol_ethers.
- Darusentan subject Category:Pyrimidines.
- Darusentan hypernym Antagonist.
- Darusentan type ChemicalSubstance.
- Darusentan type Drug.
- Darusentan type Antagonist.
- Darusentan type Chemical.
- Darusentan type Diazine.
- Darusentan type Drug.
- Darusentan type Ether.
- Darusentan type ChemicalObject.
- Darusentan type Thing.
- Darusentan type Q8386.
- Darusentan comment "Darusentan (LU-135252; HMR-4005) is an endothelin receptor antagonist.".
- Darusentan label "Darusentan".
- Darusentan sameAs m.05mqkl4.
- Darusentan sameAs Darusentan.
- Darusentan sameAs Darusentan.
- Darusentan sameAs Q5225810.
- Darusentan sameAs Q5225810.
- Darusentan wasDerivedFrom Darusentan?oldid=679804737.
- Darusentan depiction Darusentan.png.
- Darusentan isPrimaryTopicOf Darusentan.